Hospitalizations Associated With Respiratory Syncytial Virus Illness Among Children and Adolescents in Ontario, Canada
This study highlighted the burden associated with RSV hospitalizations for people aged ≤17 years and those who may be more impacted by RSV illness.
Authors
- Sophia Rodopoulou (ORCID: https://orcid.org/0000-0002-0096-9538)
- Maria Esther Perez Trejo
- Ana Gabriela Grajales
- A Goyette
- Calum S. Neish (ORCID: https://orcid.org/0009-0001-0250-1541)
- Deshayne B. Fell (ORCID: https://orcid.org/0000-0002-5548-3228)
- Natalie Nightingale (ORCID: https://orcid.org/0000-0001-9988-216X)
- Cheng Tan (ORCID: https://orcid.org/0000-0002-8764-2078)
- Sazini Nzula
Institutions
- Pfizer (United States) (US)
- IQVIA (United Kingdom) (GB)
- IQ Solutions (US)
- Pfizer (Canada) (CA)
Publication Details
- Journal
- Journal of the Pediatric Infectious Diseases Society
- Published
- 2025-08-30
- DOI
- https://doi.org/10.1093/jpids/piaf079
- Primary Topic
- Respiratory viral infections research
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Government of Ontario
- Canadian Institutes of Health Research